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Abstract
Although extremely interesting in adult neuro-glio-genesis and promising as an endogenous source for repair, parenchymal
progenitors remain largely obscure in their identity and physiology, due to a scarce availability of stage-specific markers.
What appears difficult is the distinction between real cell populations and various differentiation stages of the same
population. Here we focused on a subset of multipolar, polydendrocyte-like cells (mMap5 cells) expressing the microtubule
associated protein 5 (Map5), which is known to be present in most neurons. We characterized the morphology, phenotype,
regional distribution, proliferative dynamics, and stage-specific marker expression of these cells in the rabbit and mouse
CNS, also assessing their existence in other mammalian species. mMap5 cells were never found to co-express the Ng2
antigen. They appear to be a population of glial cells sharing features but also differences with Ng2+progenitor cells. We
show that mMap5 cells are newly generated, postmitotic parenchymal elements of the oligodendroglial lineage, thus being
a stage-specific population of polydendrocytes. Finally, we report that the number of mMap5 cells, although reduced within
the brain of adult/old animals, can increase in neurodegenerative and traumatic conditions.
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Introduction
Parenchymal progenitors have become a hot research topic in
neural plasticity since they represent intriguing players in adult
neuro-glio-genesis and a promising source of endogenous elements
for repair [1,2,3]. Most of them display neural developmental
markers of the glial lineage, in the postnatal and adult central
nervous system (CNS) being committed to the oligodendrocyte
lineage and expressing a chondroitin sulfate proteoglycan (Nerve/
glial antigen 2, Ng2; referred to as Ng2+cells [1,4,5]). The
Ng2+cells are generally considered as synantocytes [6] or
polydendrocytes [5], endowed with multiple functions in physiol-
ogy and pathology which are still far from being utterly elucidated.
A proportion of these cells persist in the adult CNS in a
phenotypically immature form [1,5,7], most of which do continue
to proliferate throughout life, thus being considered the main
cycling population of the mature mammalian CNS [8]. Although
parenchymal progenitors physiologically produce mainly glial cells
[2], in some mammals/regions they can undergo spontaneous
neurogenesis, e.g., in the rabbit striatum [9] and cerebellum [10].
Yet, also in the case of neuronal-committed cells, the primary
progenitors remain poorly identified, in contrast with their
progeny which is far more visible and characterized in its
phenotype [9,10]. The strong interest in better understanding
parenchymal progenitors crashes against the many aspects which
remain obscure about their identity, real nature, and physiology.
Among these problems, a scarce availability of stage-specific
markers along with a high heterogeneity linked to different
variables (species, age, anatomical region, etc.), make the
identification of subpopulations a hard task. More sneakily, what
appears difficult is the distinction between real cell populations and
various differentiation stages of the same population.
We have recently described a subset of glial-like cells
immunoreactive for the microtubule associated protein 5 (Map5)
in the rabbit cerebellum [10]. These cells show a morphology
(ramified, multipolar) and a molecular signature (e.g., Olig2
expression) reminiscent of synantocytes/polydendrocytes, and
some of them are newly generated within the mature cerebellar
parenchyma [10]. Intriguingly, they express a cytoskeletal-
associated molecule which is typically found in neurons (see
Table 1). The Map5 molecule [33], also referred to as Map-1B
[17], Map1X [34], or Map1.2 [35], belongs to a family of large
and fibrous microtubule associated proteins (Maps) and shows a
very wide range of expression in the CNS (summarized in Table 1).
Map5 is the first Map detectable in neurons of the developing
nervous system [36,37], expressed at high levels in growing axons/
growth cones and usually downregulated after cessation of axonal
growth [25,38] (reviewed in [39,40]). Nevertheless, the protein
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remains expressed in the whole CNS during adulthood, its
phosphorylated form reaching high levels within some regions
endowed with plasticity [11,12,19], or under conditions that elicit
axonal/synaptic plasticity in relation to physiological conditions
and in response to injury [11,41,42,43]. Map5 has also been
implicated in a number of neurological disorders, such as fragile X
syndrome [44,45], giant axonal neuropathy [46] and Alzheimer
disease [47,48].
Map5 expression is not restricted to neuronal populations
[27,28,29,30,32]. Only limited, heterogeneous information is
available concerning its localization in other cell types (Table 1).
It has mainly been reported in oligodendrocytes and Schwann cells
that produce myelin in the central and peripheral nervous system
[28,41]. In particular, it is elevated in oligodendrocytes that
initiate ensheathment of axons in the normal brain [27], and in
Schwann cells during development and nerve regeneration [41].
Map5 is generally absent in astrocytes, although its expression in
some subtypes, e.g., type1 astrocytes [29], is still controversial.
Since most of these studies were carried out in culture
[28,29,30,31,32], very little is known about the glial localization
of Map5 in vivo.
Here we focused on the distribution of Map5 in the CNS of
different mammalian species, with particular reference to a
population of multipolar, glial-like cells (here referred to as
mMap5 cells) in young/adult mice and rabbits. We characterized
their morphology, phenotype, regional distribution, and stage-
specific marker expression, as well as their occurrence in other
mammals. Finally, we investigated the behavior of mMap5 cells in
traumatic and neurodegenerative injury conditions in mice.
Results
Distribution of microtubule associated protein 5 (Map5)
in neuronal and glial cell populations of the rabbit and
mouse CNS
Firstly, we tested the cellular and regional distribution of Map5
in mature neurons of the rabbit and mouse CNS to check if the
staining obtained with our antibodies was consistent with previous
reports. The pattern of expression of Map5 in vivo, was analyzed
at three different ages (3.5, 12, and 36 months) in rabbits, and two
(40 days and 3 months) in mice, corresponding to peri-puberal and
adult ages. Consistently with previous reports, Map5 was largely
present in most CNS neurons (see references in Table 1 and
Fig. 1A). This neuronal staining was detectable in apical dendrites
and cell bodies but the nuclei were immunonegative. Large
projection neurons, such as cerebral cortex pyramidal neurons,
cerebellar Purkinje neurons, and spinal cord motorneurons were
heavily immunostained for Map5 (Fig. 1A, top). As previously
described in rodents [11,16], cerebral cortex layers II, III, V were
more intensely labeled (not shown) and staining in the olfactory
bulb was restricted to the olfactory nerve and external plexiform
layers (Fig. S1). No qualitative differences in the amount and
distribution of Map5 in neurons were detectable at the different
ages explored (see below for further age-related features).
In the whole CNS, the polyclonal anti-Map5 antiserum
employed in our study and recognizing both unphosphorilated
and phosphorilated isoforms, can be used interchangeably on
rabbit and mouse tissues, yielding an identical staining pattern
(Fig. S1). Once assessed the reliability of staining in mature
neurons, we observed that Map5 is strongly expressed in several
populations of neuroblasts which persist in the postnatal and adult
brain (Fig. 1A, middle and bottom). They include newly generated
neuronal precursors of germinal layer-derived neurogenic sites (the
forebrain subventricular zone, SVZ, and the dentate gyrus of the
hippocampus), neurogenic parenchymal progenitors of the rabbit
striatum [9], and chain of neuroblasts in the transitory subpial
layer (SPL), a secondary germinative zone of the postnatal rabbit
cerebellum [49] (Fig. 1A). By contrast, Map5 is not present in
immature or differentiating neurons, such as the PSA-NCAM+/
DCX+ immature neurons in the piriform cortex (with rare
exceptions; see Fig 1A, bottom) and the PSA-NCAM+/DCX+
newly generated neurons in the rabbit cerebellum (green
arrowheads in Fig. 1A).
Beside its wide distribution in neuronal cells, Map5 is also
detectable in a population of multipolar, glial-like cells widespread
in most CNS grey and white matter (here referred to as mMap5
cells in order to distinguish them from the Map5+neuronal
elements; Fig. 1B and red arrows in panel A). These cells, whose
shape is reminiscent of parenchymal progenitors known as
synantocytes/polydendrocytes [5,6], were far more visible in the
rabbit than in mouse, in the latter the ramified, multipolar
processes appearing not completely stained (Fig. 1B). In order to
assess this difference we quantified the total length of mMap5 cell
processes in the grey (cerebral and cerebellar cortex) and white
matter (corpus callosum) of the two species (Fig. S2A). Results
indicated that rabbit mMap5 cell process ramifications are longer
in both grey matter regions analyzed (cerebral cortex: rabbit
285,7623,5 mm versus mouse 182,1615,6 mm, P,0,05; cerebel-
lar cortex: rabbit 485,9629,5 mm versus mouse 127,1612,3 mm,
P,0,005), whereas they are similar within the corpus callosum
(rabbit 93,760,5 mm versus mouse 57,0613,5 mm, P.0,05). Such
difference was more prominent in the cerebellar cortex with
respect to cerebral cortex.
Morphologic and phenotypic characterization of mMap5
cells
In immunocytochemical specimens, multipolar Map5+cells
(mMap5 cells) and Ng2+cells showed a similar, yet not identical,
morphology (Fig. 2A). Processes revealed with Map5 are quite
smooth, without the beads, swelling and varicosities that charac-
terize the fine processes of Ng2+cells [1] (see Fig. 2A and
Discussion). Since observations carried out on mMap5 cells in
different CNS regions revealed various shapes, we performed a
quantitative analysis of cell somata diameters, by measuring their
minimum (min) and maximum extent (max) in mMap5 cells and
Ng2+cells, within three brain regions (cerebral cortex, cerebellar
cortex and corpus callosum; Fig. S2B). Comparison of the data
obtained revealed the following trend: mMap5 cell somata were
more frequently round-shaped in the cerebellar cortex (min
8,360,6 mm; max 9,460,5 mm; P.0,05), and, to a lesser extent, in
the cerebral cortex (min 7,960,8 mm; max 10,360,8 mm;
P,0,001), whereas Ng2 cell somata were more elongated (cerebral
cortex: min 5,861,0 mm; max 10,461,2 mm; cerebellar cortex:
min 5,960,9 mm; max 10,861,2 mm; P,0,001 in both regions).
On the other hand, somata of both cell types were prevalently
elongated in the white matter of the corpus callosum (mMap5
cells: min 5,861,1 mm; max 11,362,1 mm; P,0,005, and
Ng2+cells: min 5,861,0 mm; max 10,761,5 mm; P,0,005).
Double staining with NeuN, b-tub, GFAP and Iba1, consis-
tently excluded their neuronal, astroglial or microglial nature
(Fig. 2B). This fact, along with morphological features described
above, confirmed that mMap5 cells strongly resemble to a
population of glial-like, synantocyte/polydendrocyte-like cells.
They were widely distributed in all regions examined, interspersed
among the Ng2+cells (Fig. 2C; detectable in mice but not in
rabbits with immunocytochemistry, see Table 2 and [10]. As to
their amount, mMap5 cells were far less numerous than the
Ng2+cells, with an average proportion of 1:30 (semi-quantitative
Newly Generated Map5-Expressing Cells in Mammals
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evaluation on 407 Ng2+cells counted in 9 confocal images, from 3
animals, each containing at least one mMap5 cell; Fig. 2C).
Double staining with Map5 and Ng2 in mouse did not reveal any
overlapping (Fig. 2D), thus indicating that mMap5 cells are not a
subpopulation of Ng2 progenitors (although this fact does not
exclude they belong to the same lineage at a different
differentiative stage).
To further study the phenotype of the mMap5 cell population,
double and triple staining with different antigens of progenitor
cells and oligodendroglial lineage differentiation stages were
performed (Fig. 3). In all CNS regions examined the mMap5
cells were double stained with nuclear transcription factor Olig2
(Fig. 3), thus corresponding to elements of the oligodendroglial
lineage. By using Olig2/Map5 double staining as a basis for
recognizing the mMap5 cell population, the percentage of co-
expression with other antigens were calculated (histograms in
Fig. 3B). In addition to Olig2, the vast majority of the mMap5 cells
do co-express the nuclear transcription factor Sox10, and a
substantial proportion also express Sox2 and Sox9 (Fig. 3B; raw
data in Fig. S3). The pattern of marker expression strongly
indicates that mMap5 cells might represent a specific stage of
maturation along the oligodendroglial lineage, even in the absence
of overlapping between the Map5 and Ng2 markers. This is
confirmed by the fact that a proportion of mMap5 cells (4–5% in
cerebral cortex, 8 Map5+/GPR17+cells out of 179 Map5+cells,
and corpus callosum of the adult mouse, 5 Map5+/GPR17+cells
out of 122 Map5+cells; 56–84% in cerebellar grey matter, 55
Map5+/GPR17+cells out of 98 Map5+cells, and white matter, 42
Map5+/GPR17+cells out of 50 Map5+cells of the peripuberal
rabbit) is immunoreactive for the new Ng2 cell marker GPR17
receptor [52] (Fig. 3B and S3), which has been shown to be
present in 25–30% of Ng2+ cells in mice [53]. In most double
staining GPR17 appear to label the membranes of the whole
process ramifications, as previously described in more mature,
premyelinating stages [53].
Finally, we performed a careful analysis on double staining with
Map5 and RIP (a monoclonal antibody which recognizes the
CNPase specific of mature oligodendrocytes; [54]. In most
specimens, there was no co-localization (Fig. 3C), although a faint
expression of Map5 was detectable in some oligodendroglial cells
(Fig. 3C’). This suggests that Map5 expression precedes oligoden-
drocytes terminal differentiation.
Experiments with cell proliferation antigens and BrdU
pulse labeling followed by different survival times
Since mMap5 cells display most antigens expressed at different
stages of the oligodendrocyte precursor cell lineage [55,56], we
performed a set of experiments with cell proliferation markers in
order to gain more insight on their putative origin from cycling
progenitors. Double staining carried out in different CNS areas
with Map5 and Ki67 antigen (a cyclin expressed in cells during the
G1, S, G2 and M phases, but not in G0, thus in all proliferating
Table 1. Distribution of Map5 in the mammalian CNS as described in literature.
Species/region/method Age Cell type/distribution Function Refs
Neuronal
Rat CNS P0–P20, adult most neurons (complementary to Map1A) developmental/adult plasticity [11]
P3–P25, adult most neurons adult plasticity [12]
Rat CNS and PNS 2,5 months most neurons plasticity, regeneration [13]
Rat PNS E18–P30, adult peripheral nerves axonal growth in nerve
regeneration
[14]
Rat brain 3–24 months most neurons [15]
adult synaptic localization synaptic plasticity [16]
Rat brain and cultures newborn most neurons, some glial cells [17]
Rat spinal cord E9-postnatal neuroblasts morphogenic events [18]
Rat olfactory bulb adult olfactory nerve, mitral and periglomerular cells neurite outgrowth [19]
Mouse brain P5–P90 barrel cortex neurons Plasticity [20]
Mouse brain and cultures E16 neurons, neuroblasts [21]
Cat brain P3–P28, adult most neurons axon/dendritic growth,
microtubules stabilization
[22]
Human brain 13GW-17 years most neurons axonal growth [23]
18–33GW ganglionic eminence, axonal bundles axonal growth [24]
Rat cell cultures newborn symphatethic neurons axon extension [25]
Mouse Map1b mutant cell
cultures
E18–19 hippocampal pyramidal neurons axon formation [26]
Glial
Rat brain and cultures P7-adult immature oligodendrocytes myelination [27]
Primary glial cultures oligodendrocytes [28]
oligodendrocytes and type1 astrocytes [29]
oligodendrocytes, (negligible in astrocytes) Formation/stabilization of
myelin-forming processes
[30,31]
CG4 cell line oligodendrocytes [32]
doi:10.1371/journal.pone.0063258.t001
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Figure 1. Map5 distribution in neuronal and glial cells of the rabbit and mouse CNS. A, Map5 is abundant in most populations of mature
neurons (top), neuroblasts occurring in germinal layer-derived neurogenic sites or transitory germinative zones (e.g., rabbit subpial layer, SPL;
middle), and in neural progenitors of the brain parenchyma (e.g., rabbit striatum, St; bottom, left). White arrows: clusters of newly generated
neuroblasts; white arrowheads: chains of neuroblasts. Newly generated neurons in the cerebellum (Crb) and immature neurons of the piriform cortex
(Pir) are generally Map5-negative (green arrowheads; bottom, right), apart from some immature neurons which show low level of Map5 staining
(yellow arrowheads). Micrograph in panel A are from peripuberal and adult rabbit tissue, except those marked for mouse. For the Map5 staining on
the SVZ ependymal wall, see Fig. S4B. B, In addition to its neuronal localization, Map5 decorates a population of multipolar cells with the morphology
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cells, with a peak during DNA synthesis and mitosis [57]) were
consistently negative (Fig. 4A). By contrast, and as expected,
double staining between Ki67 antigen and Ng2 frequently
revealed cycling Ng2+progenitors (Fig. 4A). Ki67+/GPR17+cells
were rare and, when occurring, they showed a typical staining of
the Golgi (restricted to the cell body and absent in processes [53];
Fig. 4A). By analysing BrdU-injected mice killed at different
survival times (from 1 week to 1 month, see methods; Fig. 4B–D),
the first BrdU+/Map5+double labelling was observed starting
from 6–10 days (Fig. 4B). In parallel experiments, carried out on
rabbits, the first BrdU+/Map5+double labeling was detectable at
11–15 days survival (not shown). Hence, mMap5 cells are newly
generated in the adult mammalian CNS, yet postmitotic when
expressing this microtubulin protein, which appears 1 or 2 weeks
after cell division, depending on the animal species. Counting of
the number of BrdU+ mMap5 cells out of all BrdU+ nuclei
(percentage of newly generated mMap5 cells out of all newly
generated cells) at different survival times, in the cerebral cortex
of synantocytes (see also red arrows in panel A). These cells are better visualized in rabbit than in mouse by immunocytochemistry, since staining in
mice reveals to a lesser extent the ramifications of cell processes (schematically showed by drawings on the right; total length of cell processes
quantifications in the two mammalian species is showed in Fig. S2A). Crb, cerebellum; ML, molecular layer; Cx, cerebral cortex; Cc, corpus callosum;
SVZ, subventricular zone; LV, lateral ventricle; Sc, spinal cord; Dg, dentate gyrus of the hippocampus. Scale bars: A, 30 mm; B, 10 mm.
doi:10.1371/journal.pone.0063258.g001
Figure 2. Morphological and phenotypic characterization of mMap5 cell population. A, Despite a substantially similar appearance, mMap5
cells are slightly different from Ng2+cells as to the shape of their cell body (quantifications of cell soma diameters is showed in Fig. S2A). The
photographs are representative of two extremes: round-shaped and elongated cell bodies. B, Double staining with neuronal and glial antigens
indicate that mMap5 cells are not neurons nor astrocytes or microglia. C, mMap5 cells (arrows) are ramified elements with a morphological
appearance similar to Ng2+cells (arrowheads) but far less numerous. D, mMap5 cells and Ng2+cells belong to two distinct, non overlapping
populations. Crb, cerebellum; Cx, cerebral cortex; Cc, corpus callosum; Dg, dentate gyrus of the hippocampus. Scale bars: A,B, 10 mm; C,D, 50 mm;
inset in D, 10 mm.
doi:10.1371/journal.pone.0063258.g002
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and corpus callosum (Fig. 4E, top and Fig. S3) revealed that they
are stable at low levels in the grey matter, whereas they increase in
the white matter at 1–2 weeks, then decreasing again at 1 month.
Then, we counted the percentage of BrdU+ mMap5 cells out of all
mMap5 cells, at the time they start to be detectable as newly
generated cells in mice (end of the first week; see Fig. 4E, bottom).
We found that 13% (7 Map5+/BrdU+ cells out of 53 Map5+cells,
counted from 3 mice) and 25% (16 Map5+/BrdU+ cells out of 63
Map5+cells, from 3 mice) of the mMap5 cells are newlyborn,
respectively in the grey and white matter. Finally, we quantified
the percentage of newly generated cells immunoreactive for Ng2,
GPR17, or GST-p (number of BrdU+/marker+ cells out of all
BrdU+ nuclei) in order to compare them with those of the BrdU+
mMap5 cells (data summarized in Fig. 4E). As expected, most of
the Ng2+cells and a substantial percentage of the GPR17+cells
display active proliferation and appear to be newly generated
during the first two weeks. At the same time, GPR17 expression is
high (thus providing a link between Ng2+and mMap5 cells), then
Table 2. Primary antibodies used in this study.
Antigen Antibody/antiserum Host Dilution Source Species tested
Map5 mono, clone AA6 mouse 1:5000 Millipore R,C,GP,S,Mn,H +, M 2
poly goat 1:300 Santa Cruz M,R +
Cell proliferation
Ki67 mono mouse 1:500 BD Pharmigen M,R +
poly rabbit 1:1500 Novocastra M +, R 2
BrdU mono, BU1/75 rat 1:300 AbDSerotech M,R,C +
Progenitors cells
SOX2 poly rabbit 1:1500 Millipore M,R +
poly goat 1:400 Santa Cruz M,R +
SOX9 poly rabbit 1:1000 Millipore M,R +
Neuroblasts/Neurons
DCX poly guinea pig 1:1000 Abcam M,R +
poly rabbit 1:1000 Abcam M,R +
NeuN mono, A60 mouse 1:200 Millipore M,R +
bIII-Tub Mono (Tuj1) mouse 1:100 Millipore M,R +
bIII-Tub Poly (Tuj1) rabbit 1:1000 Covance M,R +
Astrocytes
GFAP mono mouse 1:300 Millipore M,R +
poly rabbit 1:2000 Dako M,R +
Microglia
Iba1 poly rabbit 1:1000 Wako M,R +
Ependyma
S-100b poly rabbit 1:10000 Swant M,R +
Oligodendroglia
Precursor/immature
Ng2 mono mouse 1:200 Chemicon M,R 2
mono mouse 1:500 US Biological M,R 2
poly rabbit 1:200 Chemicon M +, R2
mono mouse 1:200 Sigma M,R 2
mono mouse 1:200 Upstate M,R 2
OLIG2 poly rabbit 1:500 Millipore M,R,C +, GP,S,Mn,H 2
poly goat 1:400 R&D System M,R,C +, GP,S,Mn,H 2
SOX10 poly goat 1:1000 Santa Cruz M,R,C,GP,S,Mn +, H 2
GPR17 poly rabbit 1:10000 Marta Fumagalli M,R +
PDGFRa poly rabbit 1:1000 Santa Cruz M +, R 2
rat 1:100 BD Pharmigen M +, R 2
JAM-A poly rabbit 1:200 Santa Cruz M 2, R 2
Mature/myelinating
GST-p poly rabbit 1:400 MBL M +, R 2
RIP (CNPase) mono mouse 1:400 Chemicon M,R +
doi:10.1371/journal.pone.0063258.t002
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droppig fastly. At 1 month survival, beside a high persistence of
newlyborn Ng2+cells (more evident in the grey than white matter,
wherein they drop from 86% to 57% to 32%; see Fig. 4E) only a
few newlyborn GPR17+cells can be found (4% in both grey and
white matter). Conversely, only a few cells with features of mature
oligodendrocyte are detectable at short periods after BrdU
injection, whereas they dramatically increase at 1 month. Taken
together, results from the time course experiments show that
mMap5 cells are largely newly generated, postmitotic elements of
the oligodendroglial lineage. Furthermore, they indicate that some
mMap5 cells can differentiate into mature oligodendrocytes
(especially and more rapidly in the white matter) or maintain
the Map5 staining for undetermined times (at least 1 month; see
Figs. 4E and 5C).
Regional distribution of mMap5 cells in the CNS of
rabbits and mice
In order to verify if mMap5 cell occurrence and distribution is
widespread in the CNS and if it parallels the heterogeneity
reported in literature for the synantocyte/polydendrocyte popu-
lations, qualitative and quantitative analyses were carried out in
several CNS regions of the rabbit (cerebral cortex, corpus
callosum, striatum, cerebellum, spinal cord; Fig. 6) and mouse
(cerebral cortex, corpus callosum, cerebellum; Fig. 7). These
regions were chosen since they include both white matter tracts
and grey matter parenchyma. As stated above (see also Fig. 1B),
mMap5 cells are far less detectable in mouse tissue with respect to
rabbit, due to a different staining generally more restricted to the
cell body and primary processes in rodents (Fig. S2A). For this
reason, in parallel with regional analysis in mice (Fig. 7), we
Figure 3. Phenotypic characterization of mMap5 cells in the oligodendrocytic lineage. A, Double staining between Map5 and different
markers of the oligodendroglial lineage in mMap5 cells. B, Quantitative evaluation of mMap5 cells expressing different markers in different brain
regions. C,C’, Very low overlapping between mMap5 cells and the mature oligodendrocytic population. Double staining with Map5 and mAb anti-RIP
(CNPase) in the mouse cerebral cortex (Cx) generally showed no co-expression (C); a faint overlapping of the two antigens could be detectable only in
some cells (C’, arrows). Scale bars: 10 mm.
doi:10.1371/journal.pone.0063258.g003
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performed a more widespread study in different areas of the rabbit
CNS (Fig. 6). Morphological variations in the overall cell shape
were observed, with particular differences in white and grey
matter. Most mMap5 cells had a round soma from which 3–4
main processes radiate in all directions. In grey matter they were
arranged among the neuronal cell bodies, and their processes
occupied a roughly spherical territory (Figs. 6 and 7). In the
cerebral cortex (both six- and three-layered regions) the mMap5
cells were often resting on neuronal somata and processes (Fig. 1A,
bottom). Quantification of mouse cell soma diameters in this
region is reported in Fig. S2B. In the cerebellum they were
associated with Purkinje cell somata, in this case assuming a more
flattened shape, or widespread in the cortex with a soma
prevalently round-shaped (quantification of mouse cell soma
diameters in Fig. S2B). In white matter (e.g., corpus callosum
and spinal cord fiber tracts), the cell bodies were more flattened/
elongated with few short processes starting from the two poles and
trapped in-between myelinated axons (Figs. 1B and 6A; quanti-
fication of mouse cell soma diameters in Fig. S2B), which are
reminiscent of the GPR17+cells detected by Lecca et al. [58]. The
most ramified, typically stellate morphology was frequently
detectable in the granule layer and molecular layer of the
cerebellum, and to a lesser extent in the striatum. mMap5 cells
in the cerebral cortex and spinal cord grey matter were more
irregular/heterogeneous in their overall shape, frequently en-
dowed with three main processes (Fig. 6A, bottom). In the spinal
cord grey matter mMap5 cells were more abundant in the
intermediate zone, less abundant in the dorsal horn, and rare in
the ventral horn (Fig. 6A, bottom). The wider variety of different
shapes was detectable in the spinal cord white matter, with many
bipolar and neuronal-like, pyramidal morphologies (Fig. 6A,
bottom). These shapes were unusual with respect to the multipolar
aspect of mMap5 cells in other regions.
Hence, some differences (more flattened in white matter, more
multipolar in grey matter) substantially reflect those described for
the Ng2+cells [1]. Nevertheless, our analysis of cell soma diameters
revealed higher heterogeneity for mMap5 cells in some CNS areas
with respect to that described for Ng2+cells (see Fig. S2B).
In order to assess the number of mMap5 cells in different CNS
regions, cell densities were counted in all the areas examined, at
different ages. Quantification results are reported in histograms of
Fig. 6 (rabbit) and 7 (mouse). In general, mMap5 cells are quite
numerous in the white matter with respect to grey matter, both in
rabbits and mice (see statistics in Figs. 6 and 7). Yet, this difference
is remarkable only in young animals, since the number of mMap5
cells in the white matter falls after puberty (see statistics in Figs. 6
and 7, and below for age-related considerations). This substantial
reduction of mMap5 cell density in the shift from the peripuberal
to adult period is particularly evident in large bundles of axons of
the corpus callosum and spinal cord dorsal columns. The age-
related drop is more evident in mice, due to a higher initial cell
density in rodents with respect to lagomorphs. At subsequent ages
the cell densities seem quite stabilized, even in old animals (e.g., in
1-year old mice; value referred to a different strain).
Comparative analysis of mMap5 cells occurrence in other
mammals
In addition to the systematic analysis in most regions of the
rabbit CNS and mouse brain, we analyzed brain tissue sections
from other mammalian species characterized by increasing brain
size and neocortex complexity (guinea pig, cat, sheep, monkey,
human; Fig. 8). Different regions, including cerebral cortex,
striatum, cerebellum, and different ages, up to 70 years in humans,
were considered. Multipolar Map5+cells were found in all species,
regions and ages investigated. In most cases, compatibly with tissue
fixation/antibodies successful staining, these cells showed co-
expression with markers tested in rabbit and mouse, thus
confirming they belong to the mMap5 cell population (Fig. 8).
The wide range of presence of mMap5 cells in the CNS of
different mammals indicates a common role/distribution in
phylogeny, including humans.
mMap5 cell distribution in chronic neurodegenerative
damage and in acute trauma
Although many reports indicate the general involvement of
Map5 molecule in different pathological conditions [40], the
participation of mMap5 cells is still unknown. To gain more
insight into the role of mMap5 cells in chronic damage we
extended our analysis to a mouse transgenic model of neurode-
generation (APPPS1, a model of Alzheimer’s Disease; [59].
Notably, the density of Olig2+mMap5 cells was significantly
increased in the APPPS1 cortical grey matter compared with age-
matched WT controls (2,160,4 cells/mm2 in APPPS1 versus
0,360,1 cells/mm2 in WT, p,0.001; Fig. 9A). The number of
Olig2+mMap5 cells was also significantly increased in the white
matter of the corpus callosum (461 cells/mm2 in APPPS1 versus
0,560,5 cells/mm2 in WT, p,0.05; Fig. 9A). To address the issue
of a possible involvement of mMap5 cells in acute trauma
conditions, we analyzed the cerebral cortex and corpus callosum of
mice after stab wound (SW) injury. At 15 days post-lesion the
density of Olig2+mMap5 cells in the grey matter was similar to
that detectable in intact mice (2,660,2 cells/mm2 in SW, versus
1,960,4 cells/mm2 in control, p.0.05; Fig. 9B). By contrast, the
number of Olig2+mMap5 cells was significantly increased in the
underlying white matter (10,861,8 cells/mm2 in SW versus
4,961,7 cells/mm2 in control, p,0.05; Fig. 9B). This result is
consistent with previous studies reporting that GPR17, which is
also expressed by these Olig2+mMap5 cells, is significantly
increased in both the APPPS1 model and after induction of SW
in rodents [53].
Hence, our data show that a substantial increase of mMap5 cells
does occur in chronic neurodegenerative conditions (both in grey
and white matter), and, to a lesser extent, after traumatic injury (in
the white matter only).
Map5 expression and mMap5 cells at different ages
Since the amount of polydendrocytes remarkably varies with
age [60,61], we analysed the behavior of mMap5 cells at different
postnatal (peripuberal and adult) stages (Fig. 10). First of all,
western blots of protein lysate from total brain of mouse (40 days
and 3 months old), and rabbit (3,5 months and 1 year old), probed
with anti-Map5 and normalized with anti-vinculin antibodies,
were performed. Values (from older animals expressed relatively to
young animals of the same species) indicated that total level of
Map5 did not change significantly with respect to age (Fig. 10A).
This result must be read as the total amount of neuronal and glial
Map5, although we know that it is prevalently expressed in
neurons (see first paragraph of the Result section and Fig. 1). By
contrast, counting of the mMap5 cells at different ages clearly
indicated their progressive reduction from peripuberal to adult
stages, more dramatic in the white matter (regional data in rabbit
and mouse are reported in Figs. 6 and 7; the trend of average data
from all regions examined is summarized in Fig. 10B). Their level
then results stabilized during adulthood and in old individuals (the
latter data are referred to 1 year old mice of the C57BL/6 strain).
On the whole, by comparing Map5 expression in peripuberal and
young/adult rabbits with age matched mice, in both species we
observed no significant reduction of the total Map5 molecule
Newly Generated Map5-Expressing Cells in Mammals
PLOS ONE | www.plosone.org 8 May 2013 | Volume 8 | Issue 5 | e63258
Figure 4. Genesis and differentiation of mMap5 cells in mice. Analyses carried out with endogenous and exogenous cell proliferation markers
in double staining with Map5 and other markers of the oligodendroglial lineage. A, No proliferation of mMap5 cells is detectable by using the
endogenous cell proliferation marker Ki67, whereas most Ng2+cells are clearly cycling. Rare Ki67+/GPR17+cells are detectable (A, right), their staining
being restricted to the Golgi in the cell body (arrowhead). B–D, Analyses carried out with BrdU i.p. administration followed by different survival times
(from 10 to 30 days). BrdU/Map5 double staining is detectable starting from 5–10 days in mice. E (top), quantification of newly generated cells
expressing Map5, Ng2, GPR17, GST-p, at different BrdU post-injection survival times, in grey (GM, cortex) and white matter (WM, corpus callosum).
Data indicate the percentage of BrdU+/marker+ cells out of total BrdU+ nuclei (raw data are reported in Fig. S3). E (bottom), quantification of newly
generated mMap5 cells out of the mMap5 cell whole population (analysed in animals with 5+5 days BrdU treatment). Scale bars: 10 mm.
doi:10.1371/journal.pone.0063258.g004
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amount with age (Fig. 10A), but significant reduction of the
mMap5 cell number, especially in the white matter (see graphics in
Fig. 10B, and rabbit, mouse regional data in Figs. 6 and 7).
Discussion
In the adult mammalian CNS, beside de novo cell genesis of
‘classic’ neurogenic sites (SVZ and dentate gyrus [62,63]), the
occurrence of local, parenchymal progenitors which continue to
divide throughout life has progressively became a new area of
investigation [1,2,64,65]. In vivo, these cells are different from
neural stem cells, since they are not segregated within germinal
layer-derived, highly regulated niches [66,67]. Parenchymal
progenitors are widespread in the CNS tissue, so that they do
not need to migrate to reach the injured sites (see [3] for review).
They can react to brain injury in different ways [68,69,70],
whereas neurogenesis supported by the stem cell niches appears
functionally committed to restricted physiological roles and poorly
supportive for repair [71,72].
In spite of the indisputable interest for parenchymal progenitors,
our knowledge of their biology remains incomplete due to a
remarkable difficulty in defining cell populations/subpopulations
which often display regional features and different degrees of
differentiation, not always revealed by specific markers. Here we
analysed the cellular and molecular features of a subset of
multipolar cells immunoreactive for Map5, a microtubule-
associated protein expressed in both neurons and glia [40]. In
the past, the glial localization of Map5 has been underestimated.
This fact could be attributable to the different appearance of
Figure 5. Schematic summary of the spatial and temporal distribution of several markers linked to the mMap5 cell population. A,
The mMap5 cell population can be revealed by Map5/Olig2 double staining, and the subset of newly generated mMap5 cells by Map5/Olig2/BrdU
triple staining (left). Double and triple staining with different markers (see colors in the legend on the right) can provide information on the spatial (B)
and temporal (C) distribution of different subpopulations. B, The relative amount of each cell population revealed by different markers is indicated by
colored squares. There is no overlapping between mMap5 and Ng2+cell population, and only a very small overlapping with the GST-p+
oligodendrocytes. C, Hypothesis on the time course for newly generated mMap5 cells by using endogenous and exogenous cell proliferation
markers.
doi:10.1371/journal.pone.0063258.g005
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Figure 6. Regional distribution of mMap5 cells in the rabbit CNS. A, Representative images of mMap5 cells in the cerebral cortex (Cx), corpus
callosum (Cc), striatum (St), cerebellum (Crb), and spinal cord (Sc). g, grey matter; w, white matter; vh, ventral horn; iz, intermediate zone; c, central
canal. B, Quantitative analysis of mMap5 cell density in different regions, at three different ages. Squares indicate the areas in which cell counts have
been carried out. Asterisks/dots indicate significant statistical differences in mMap5 cell densities among different regions/ages (two way ANOVA,
p,0,001). Scale bars: Low magnifications, 50 mm; high magnifications, 10 mm.
doi:10.1371/journal.pone.0063258.g006
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mMap5 cells in mice and rabbits described here, which likely
contributed to the ‘hiding’ of mMap5 cells in previous studies
carried out on rodents (see for example [13,29]).
mMap5 cells are a population of newly generated,
postmitotic parenchymal elements of the
oligodendroglial lineage
Although widely expressed in different types of neuronal cells
(mature neurons and neuroblasts generated from both neural stem
cells and parenchymal progenitors), Map5 also decorates a subset
of multipolar glial-like cells (Fig. 1). We show that these multipolar
elements, here referred to as mMap5 cells, are not neurons, nor
astrocytes or microglia, and consistently express Olig2, Sox10,
and, to a lesser extent, Sox9 and Sox2 transcription factors in their
nuclei (Figs. 2 and 3). Olig2 is necessary for oligodendrocyte
lineage development in multipotent progenitor cells of the embryo
and adult [73]. The transcription factors Sox9 and Sox10 jointly
occur in cells of the oligodendrocyte lineage, being important for
their specification and terminal differentiation [74]. Sox9, also
expressed in astrocytes, in the oligodendrocyte lineage marks the
stage of immature oligodendrocyte precursors, then being turned
off during maturation. Sox10 is not expressed in all CNS glial cells,
being restricted to the oligodendrocyte lineage. With the onset of
specification, Sox10 starts to be expressed in proliferating
oligodendrocyte progenitors and persists in mature, terminally
differentiated oligodendrocytes (reviewed in [74]). On the whole,
the pattern of molecular expression found in mMap5 cells clearly
places them in the oligodendroglial lineage. In addition, some
mMap5 cells also express Sox2, a transcription factor involved in
neural stem/progenitor cell maintenance [75]. This raises the
question if either all mMap5 cells are committed to the
oligodendroglial lineage or some of them might retain properties
of immature/progenitor cells. To answer this question, we
performed a study on cell proliferation dynamics, by using
different cell division markers (Fig. 4). Our results obtained with
the endogenous cell proliferation marker Ki67 demonstrate that
mMap5 cells are not cycling elements (as the Ng2+progenitors are
[1,2]). Nevertheless, BrdU injections followed by different survival
times showed that, even if postmitotic, when expressing the Map5
molecule a substantial proportion of these cells is newly generated
(25% of all the mMap5 cells and 20% of cells which are newly
generated at 10–15 days post-injection; data detected with our
BrdU injection protocols, which cannot reveal all the newlyborn
cells and thus underestimate the total number of newly generated
mMap5 cells). It is interesting to note that, unlike Map5 expression
Figure 7. Regional distribution of mMap5 in the mouse CNS. A, Representative images of mMap5 cells in the cerebral cortex (Cx), corpus
callosum (Cc), striatum (St), cerebellum (Crb). g, grey matter; w, white matter. B, Quantitative analysis of mMap5 cell density in different regions, at
two different ages. Squares indicate the areas in which cell counts have been carried out. Asterisks/dots indicate significant statistical differences in
mMap5 cell densities among different regions/ages (two way ANOVA, p,0,001). Scale bars: Low magnifications, 50 mm; high magnifications, 10 mm.
doi:10.1371/journal.pone.0063258.g007
Newly Generated Map5-Expressing Cells in Mammals
PLOS ONE | www.plosone.org 12 May 2013 | Volume 8 | Issue 5 | e63258
in neurons, which spans from progenitors of the ventricular zone
to fully mature neurons (our data in the adult, but see also [21] in
the embryonic ventricular zone), in the glial lineage Map5 is
expressed in newly generated cells, but only when they are
postmitotic. In other words, although mMap5 cells are not actively
proliferating, new mMap5 cells are generated from cycling cells,
thus inserting them in a stage-specific state of oligodendroglial-like
precursors (deriving from parenchymal progenitors, as confirmed
by co-expression of GPR17; see below).
Beside morphological and molecular aspects strongly reminis-
cent of sinantocytes/polydendrocytes [1,2,5], the mMap5 cells also
show different features: their processes are quite smooth, without
swelling and varicosities typical of Ng2+cell processes [1]; such
difference is qualitative and linked to the cytoskeletal nature of
Map5 with respect to the membrane-bound localization of Ng2.
Due to the high number of Ng2+cells with complex and
overlapping processes, an in vivo quantification of ramifications
could be unreliable. In addition, the cytoskeletal protein Map5
could not fill the whole extent of cell process ramifications. For
these reasons we chose to quantify the cell somata diameter of both
mMap5 and Ng2+cells. Soma diameters of Ng2+cells were
prevalently elongated and rather constant in all regions, whereas
those belonging to mMap5 cells are more heterogeneous, being
prevalently round-shaped in grey matter. As expected, the average
soma diameter was not significantly different in the three regions
and its mean value (8,960,1 mm) is very similar to that recently
reported for a subset of premyelinating cells (9,760,9 mm;
detected in Lucifer yellow-filled cells in PLP-GFP mice [50]).
Taken together, these features suggest that mMap5 cells could be
elements which derive from parenchymal progenitor cell division,
yet being in a non-cycling, more stable and specialized/
differentiated stage.
Even though Map5 and Ng2 never co-localize, mMap5 cells
may represent a small population of more mature, ‘intermediate’
cells deriving from Ng2 precursors that have already dowregulated
this proteoglycan during their differentiation pathway. Support to
this view comes from the expression analysis of GPR17, a
membrane G-protein coupled receptor recently deorphanized
[76], which has been shown to represent a new Ng2 cell marker
[52] and to occur in oligodendrocyte precursor cells [58] as a
transiently expressed functional modulator [52,53,77]. In detail,
GPR17 has been shown to decorate two distinct differentiation
stages of Ng2+cells: an early stage of still proliferating cells
expressing GPR17 mainly in the cell body along with other
precocious markers (e.g., platelet-derived growth factor receptor
alpha, PDGFRa), and a more advanced post-mitotic stage, at
which cells are losing Ng2 but GPR17 is maximally upregulated in
cell processes [52,53]. Our findings show that GPR17 is also
detectable in a proportion of mMap5 cells (Figs. 4 and 5B), thus
suggesting that Map5 specifically labels this second transition state
(see also below) and is most probably expressed in-between two
distinct stages of differentiation (Fig. 5C). GPR17 is upregulated in
cells which assume premyelinating features, after having lost Ng2
and having expressed the receptor in the cell processes [53].
Accordingly, we found GPR17 cellular localization in somata and
processes of mMap5 cells, which is, again, consistent with a more
mature stage.
In order to provide a more complete picture of all newly
generated cells in the oligodendroglial lineage, we extended the
time-course experiments to the relative markers. In mice injected
with BrdU and killed at different survival times, we analyzed and
quantified the percentages of co-expression between the prolifer-
ation marker and different oligodendroglial cell markers (Fig. 4).
Map5 does not colocalize with BrdU prior than 10 days post
Figure 8. Occurrence of mMap5 in different mammals.
Multipolar, Map5+cells showing the same morphology and set of
markers found in mouse and rabbit are detectable in various CNS
regions of different mammals, including humans. Scale bars: 10 mm.
doi:10.1371/journal.pone.0063258.g008
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injection, thus confirming that at least 1 week is necessary before
its expression in newly born mMap5 cells (2 weeks in rabbit, as
found in parallel experiments carried out on this species). Starting
from the second week, the percentage of Ng2+/BrdU+ double
labeled cells decreases in parallel to an increase in the number of
BrdU+ mMap5 cells. This trend confirms that new mMap5 cells,
although not actively proliferating, are generated from cycling cells
(most likely Ng2+progenitors). On the other hand, the increase in
percentage of cells co-expressing BrdU and the mature oligoden-
drocyte marker GST-p detectable at subsequent times, suggests
that some mMap5 cells might differentiate into oligodendrocytes.
It is important to note that both decrease of Ng2+newly generated
cells and increase of mMap5 newly generated cells are far more
visible in the white matter (while almost stable in the grey matter;
see Fig. 4E). This pattern supports the hypothesis that mMap5
cells are an intermediate stage between Ng2+progenitors and
oligodendrocytes in the white matter, yet leaving open possibilities
for other roles in the grey matter.
mMap5 cells are reduced in number during adult/old
ages but can increase after brain damage
Previous studies indicated that Map5 expression is high during
development and at peri-natal stages [11,40], then undergoing an
early post-natal reduction to persist at lower levels in the
peripuberal and adult CNS (see for example quantitative data
on western blots from rat cerebral cortex and spinal cord, in [37]).
Here, we confirm that the total amount of Map5 molecule in brain
lysates remains substantially unchanged during adulthood, a trend
which is clearly due to the prevalent expression of the protein in
mature neurons throughout the CNS, as also observed qualita-
tively in immunocytochemical specimens.
In parallel to the total Map5 expression, as shown by our cell
counts, the mMap5 glial cells do represent a very small cell
population, even smaller that the NG2+cells (about 1:30; see Figs. 2
and 5). Quantification of the mMap5 cell densities in both mouse
and rabbit, revealed that their number decreases dramatically
during the peripuberal period (Figs. 6, 7 and 10), at later stages
with respect to that observed for neurons, being likely related to
the last phases of myelination [78]. Indeed, the drop in mMap5
cells is particularly evident within large white matter tracts, and by
comparing the two mammalian species, it starts from absolute
values which are higher in mice, then following a similar trend
although more diluted in rabbits (Fig. 10B).
Our data indicate that even if the number of mMap5 cells
becomes stabilized at low levels at adult/old ages, in some injury/
pathology situations their number can increase again (Fig. 10C).
This increase seems to be more evident in chronic neurodegen-
erative states with respect to traumatic events, and, surprisingly, in
grey matter with respect to white matter (Fig. 9). In this context, it
is interesting to note that while the dramatic decrease observed
during postnatal development does occur mainly in white matter
(likely linked to the last phases of myelination), the increase
detected in APPPS1 mice is higher in the cerebral cortex grey
matter. This fact, even taking into account that neurodegenerative
lesions are less evident in the white matter, opens the possibility
that mMap5 cells could subserve other functions within the
lesioned parenchyma. However, the more prominent increase
observed in chronic neurodegeneration with respect to acute
trauma could be linked to temptative myelinization.
In conclusion, we show that mMap5 cells represent a subset of
newly generated cells in the CNS parenchyma. These cells occur
in the nervous tissue of most mammalian species, including
humans, wherein they can be easily identified with a stage-specific
marker, thus allowing further studies on their behavior in different
physiological and pathological conditions.
Figure 9. Behavior of mMap5 cells under neurodegenerative and traumatic injury conditions in mice. A, The number of mMap5 is
significantly increased in the cerebral cortex (Cx) and corpus callosum (Cc) of APPPS1 trangenic mice. Asterisks, amyloid plaques. B, A slight increase
in the amount of mMap5 is detectable after stab wound lesion in the mouse cerebral cortex and corpus callosum. Differences between A and B in the
number of mMap5 in WT animals is related to the different ages at which the two lesion models were analysed (12 months for Alzheimer and 3
months for stab wound). Scale bars: Low magnifications, 50 mm; high magnifications, 10 mm.
doi:10.1371/journal.pone.0063258.g009
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Methods
Animals and tissue preparation
All experimental procedures were in accordance with the
European Communities Council Directive of 24 November 1986
(86-609 EU) and the Italian law for the care and use of
experimental animals (DL.vo 116/92). Experiments carried out
in this study were approved by the Italian Ministry of Health (8
october 2009) and the Bioethical Committee of the University of
Turin. Mice and rabbits were raised in the NICO animal facility
(authorization n. 182/2010-A). All experiments were designed to
minimize the numbers of animals used and their discomfort. Six
peripuberal (3,5 months old), three young (1 year old) and three
adult (3 years old) female New Zealand White (Oryctolagus cuniculus),
3 peripuberal (40 days old) and 12 adult (3 months old) CD-1 mice
(Mus musculus), were used. In addition, to extend the comparative
analysis, some sample tissues of other mammalian species were
provided through collaborations with other Institutions. Fixed
brain sections were obtained from: one female albino Dunkin-
Hartley guinea pig (Cavia porcellus, 30 days old) provided by Dpt. of
Animal and Human Biology, University of Turin (authorization of
the Italian Ministry of Health number 66/99-A); one adult cat
(Felis silvestris catus, 18 months old) provided by Dept. de Fisiologı´a
y Zoologı´a, Sevilla, Spain (Servicio de Animales de Experimenta-
cio´n, Universidad de Co´rdoba, Spain; approved by the Committee
on Bioethics of the Vale`ncia University (R.D. 120/2005 BOE
252/34367-91, 2005); one young female sheep (Ovis aries, 2 months
old) provided by Istituto Zooprofilattico Sperimentale del
Piemonte, Liguria e Valle d’Aosta (post-mortem material collected
at a local slaughter house: Old Bear S.a.s. Cuneo, Ronchi, Italy);
one adult male macaque monkey (Macaca fascicularis, 8 years old)
provided by Dpt. of Physiology and Pharmacology of the
Figure 10. Amount of Map5 molecule and mMap5 cells in the rabbit and mouse CNS at different ages. A, Immunoblot analysis of Map5
(Map1b) expression in different animals at different ages. Autoradiography of the western blot of protein lysate from total brain of mouse 40 days old
(a) and 3 months old (b), rabbit 3,5 months old (c) and 1 year old (d), probed with anti-Map5 and anti-vinculin antibodies (3 animals for each
condition). On the right, quantitation of the image after normalization with vinculin. The values expressed are a media of the value of the 3 animals
for each condition. Values of older animals were expressed relatively to those of young animals of the same species. Level of Map5 in the brain of the
older animals does not change significantly with respect to level in the young animals of the same species. B, Trend in the amount of mMap5 cells in
the rabbit and mouse CNS at different ages. C, Schematic representation of the data reported in B, and reactivity of mMap5 after injury.
doi:10.1371/journal.pone.0063258.g010
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University of Rome Sapienza, Italy (authorization of the Italian
Ministry of Health 27 september 2010; the animal was housed not
in single cage but in a large common, enriched environment with
other animals, with free access to food and water, in order to
minimize any discomfort and suffering; it was sacrificed for the
study of cerebral connectivity). An autoptic tissue sample of the
human cerebellum belonging to a woman, 70 years old, was kindly
provided by Department of Clinical and Biological Sciences,
University of Turin, Italy (sample anonymized for analysis, from a
tissue bank; procedure approved by the local Ethical Committee -
San Luigi Hospital, Orbassano, Italy, n. 191/INT). Three
APPPS1 mice (12 months old, raised in the animal house of
NICO research center; authorization Italian Ministry of Health,
17 october 2011) were used as a model of chronic damage (chronic
amyloid deposition; Radde et al., 2006); we examined three age
matched C57BL/6 as wild-type littermates (authorization as for
the APPPS1 mice).
Animals were deeply anesthetized (ketamine 100 mg/kg -
Ketavet, Bayern, Leverkusen, Germany - and xylazine 33 mg/
kg body weight (5 mg/kg in mice) - Rompun; Bayer, Milan, Italy -
for rabbit and guinea pig; sodium pentobarbital 50 mg/kg, i.p., for
cat; ketamine 5–10 mg/kg, i.m. and metomidine 30 mg/kg, i.m.,
for monkey) and perfused intracardially (apart from sheep,
perfused in the head through the carotid artery after slaughtery)
with a heparinized saline solution followed by 4% paraformalde-
hyde in 0.1 M sodium phosphate buffer, pH 7.4. Brains were then
postfixed (2 hs, mice; 6 hs, rabbits and guinea pig; overnight,
monkey; 48 hs, sheep), cryoprotected with increasing concentra-
tion of sucrose/0.1 M PB, till 30%, frozen at280uC, and cryostat
sectioned (40 mm thick). The human cerebellar tissue was fixed in
formalin for 1 hr then in 4% paraformaldehyde in 0.1 M sodium
phosphate buffer, pH 7.4, overnight.
BrdU injections and surgical procedures
Nine mice received one daily injection of BrdU (Sigma-Aldrich;
40 mg/Kg) for 5 consecutive days and then were killed 5 days
(n = 3), 10 days (n = 3), 30 days (n = 3), after the last injection. Six
rabbits received one daily injection of BrdU for 5 consecutive days
and then were killed 5 days (n = 2, peripuberal), 10 days (n = 4; 2
peripuberal, 2 young), after the last injection. The cat received one
daily injection of BrdU for 2 consecutive days and was killed 19
days after the last injection.
Stab wound was performed on three 3 months old CD1 mice.
Surgical procedures were carried out under deep anesthesia
(ketamine, 100 mg/Kg; Ketavet, Bayern, Leverkusen, Germany;
xylazine, 5 mg/Kg; Rompun; Bayer, Milan, Italy). A stab-wound
in the right cerebral cortex (Bregma from20.4 mm to22 mm,
laterolateral 1.5 to 2.5 mm) encompassing both gray and white
matter was performed, then animals were killed 15 days after
lesion. The controlateral part of the cortex was used as control.
Immunohistochemistry
Immunohistochemical reactions were performed on free-float-
ing sections incubated in blocking buffer (5% normal serum, 0.3%
Triton X-100 in 0.01 M PBS, pH 7.4) for 1 h at RT, and then
incubated for 24–48 h at 4uC in a solution of 0.01 M PBS,
pH 7.4, containing 0.1–1% Triton X-100, 2% normal serum and
the primary antibodies (Table 2). For BrdU staining, DNA was
denatured in 2N HCl, 0.5% Triton X-100 for 30 min at 37uC.
Sections were then rinsed in 0.1 M borate buffer, pH 8.5 for 20
minutes. Following primary antisera incubation, sections were
incubated with appropriate solutions of secondary AMCA-
conjugated (1:200; Jackson ImmunoResearch, West Grove, PA),
cyanine 3 (Cy3)-conjugated (1:800; Jackson ImmunoResearch,
West Grove, PA), Alexa488-conjugated (1:400; Molecular Probes,
Eugene, OR) and dylight 649-conjugated (1:400, Jackson Im-
munoResearch, West Grove, PA) antibodies, for 2 hours RT.
GD/17 was detected with the high sensitivity Tyramide signal
amplification system (Perkin Elmer Life Sciences). Sections were
counterstained with 4’,6-diamidino-2-phenylindole (DAPI, KPL,
Gaithersburg, Maryland USA), mounted with MOWIOL 4-88
(Calbiochem, Lajolla, CA) and examined using an E-800 Nikon
microscope (Nikon, Melville, NY) connected to a colour CCD
Camera, and a Leica TCS SP5 (Leica Microsystems, Wetzlar,
Germany) confocal microscope.
Image processing and data analysis
All images were collected with the confocal microscope. Images
were processed using Adobe Photoshop CS4 (Adobe Systems, San
Jose, CA). Only general adjustments to color, contrast, and
brightness were made.
Quantitative analysis (cell densities, marker coexpression, soma
diameters and cell process lenght) were performed by means of the
Neurolucida software (Micro-Brightfield, Colchester,VT), Imaris
7.4.2 software (Bitplane AG, Zurich, Switzerland) or by confocal
analysis. Countings has been conducted on 3 to 5 representative
coronal (brain) or sagittal (cerebellum) cryostat sections, from each
animal. Three animals were analyzed for each time point or
experimental condition. For cell densities: the areas of the regions
of interest were determined per section using a suitably calibrated
Neurolucida-microscope setup. Data are expressed as densities
(cell/mm2) and presented as means 6 SEM. For multiple/double
staining, the number of inspected cells ranged from 50 to 300 in
total / 3 animals (see also S2). For Ki67 and BrdU staining, at least
50 cells in total / 3 animals were analyzed (see also S2). For
morphometric analysis (soma diameters, total process lenght), at
least 30 cells were randomly chosen in each area analyzed in three
animals. We analyzed three different CNS areas: cerebral cortex,
corpus callosum and cerebellar cortex. The soma diameter was
calculated for each cell by measuring its minimum (min) and
maximum extent (max) in two orthogonal directions (Fig. S2B).
Average soma diameter was obtained averaging the two values.
The total length of mMap5 cell processes was calculated on
confocal images processed with Imaris 7.4.2 software, using the
‘‘Autopath’’ filament function, to trace labeled processes. All
morphometric data were presented as means6 SEM.
Statistical analysis was carried out by the Statistical Package for
the Social Science 14.0 (SPSS, Chicago, IL) and included two way
ANOVA test followed by Bonferroni’s post hoc analysis (to
compare mean values) and Student’s t test (to compare two
groups). P,0.05 was considered statistically significant.
Western blots
Animals were sacrificed at 40 days and 3 months (mouse, n = 6),
3,5 months and 1 year (rabbit, n = 6); brains were collected and
then immediately homogenized in a glass-Teflon Potter homog-
enizer in an ice-cold lysis buffer containing 20 mM Hepes,
pH 7.5/10 mM KCl/1.5 mM MgCl2/1 mM ethylenediamine-
tetraacetic acid (EDTA)/1 mM ethylene glycol tetraacetic acid
(EGTA)/1 mM DTT/0.5% CHAPS/complete protease inhibi-
tors; Roche Cat. No. 11 697 498 001). The homogenates were
centrifuged at 12000 rpm for 15 min at 4uC. Protein concentra-
tion was determined using a Bradford assay #23236. Proteins
extracts (50 mg) were separated on SDS-PAGE (6% polyacrila-
mide) and transferred to polyvinylidene difluoride membranes.
Then the membranes were blocked in 5% nonfat milk in tris
buffered saline (TBS)-T (200 mM Tris and 1.5 M NaCl with 0.1%
Tween 20) and were incubated with primary antibody diluted in
Newly Generated Map5-Expressing Cells in Mammals
PLOS ONE | www.plosone.org 16 May 2013 | Volume 8 | Issue 5 | e63258
TBS-T overnight at 4uC. The membranes were washed and
incubated with secondary horseradish peroxidase-coupled anti-
bodies (Santa Cruz Biotechnology, Santa Cruz, CA) in TBS-T for
1 hour at room temperature. After the final washes, the proteins
were detected by enhanced chemiluminescence. The bands were
quantified using Quantity OneH 1-D Analysis Software (Bio-Rad
Laboratories) and values were normalized with respect to
Vinculin. The values were expressed as a percentage relative to
the sham level of OD. The values of the old animals were
expressed relatively those of the young animals of the same species.
The antibodies and dilution used were as follows: anti-Map5
polyclonal 1:1000 (see Table 2), anti-vinculin, poyclonal goat,
1:1000 (Santa Cruz).
Supporting Information
Figure S1 Staining with anti-Map5 antibodies used in
this study on the olfactory bulb of rabbits and mice. Both
mouse monoclonal and goat policlonal anti-Map5 reveal the same
pattern of immunocytochemical distribution in the olfactory bulb
(OB) of different mammalian species. As previously described [11],
Map5 (Map1B) is heavily expressed in the olfactory nerve layer
(ONL) and external plexiform layer (EPL) of young/adult animals.
GL, glomerular layer; GrL, granule layer. Scale bars: 50 mm.
(TIF)
Figure S2 Quantifications carried out on cell processes
of mMap5 cells in rabbit and mouse, and on cell bodies
of mMap5 and Ng2+cells in mouse. A, The entire extension
of mMap5 cell processes was drawn using Imaris software (left) in
grey and white matter regions of rabbit and mouse. Results (right)
indicated that mMap5 cells have longer cell processes (cell process
total length) in rabbit than in mouse in both the grey matter
regions analyzed (cerebral cortex, Cx; cerebellar cortex, Crb),
whereas no significant differences were detectable in white matter
(corpus callosum, CC). B, the soma diameter was calculated for
each cell by measuring its minimum (min) and maximum (max)
extent in two orthogonal directions (middle) and averaging the two
values (right). Soma diameters of Ng2+cells are prevalently
elongated and rather constant in all regions, whereas those
belonging to mMap5 cells are prevalently round-shaped in grey
matter regions and elongated in white matter. On the whole, the
mMap5 cell somata are more heterogeneous. As expected, the
average soma diameters are not significantly different.
(TIF)
Figure S3 Tables with raw data used for quantifications
of newly generated cells and subpopulations of mMap5
expressing different markers.
(DOCX)
Figure S4 A. Map5/b-Tub (Tuj1) double staining in the
cerebellum of rabbit and mouse. No overlapping between the
two antigens is detectable. B, High magnification confocal images
of Map5 staining in the SVZ. Note that many ependymal cells (e)
are stained with the anti-Map5 antibody; the Map5 staining is not
overlapping with GFAP, and partially overlapping with DCX. LV,
lateral ventricle; dlc, dorso-lateral corner; vlw, ventral-lateral wall.
(TIF)
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